Cargando…
Acetyl-CoA Carboxylase Inhibition as a Therapeutic Tool in the Battle Against NASH: Hitting More Than Just One Mechanism?
Autores principales: | Lambrecht, Joeri, Tacke, Frank |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573675/ https://www.ncbi.nlm.nih.gov/pubmed/32730829 http://dx.doi.org/10.1016/j.jcmgh.2020.07.002 |
Ejemplares similares
-
Acetyl-CoA Carboxylase Inhibition Improves Multiple Dimensions of NASH Pathogenesis in Model Systems
por: Ross, Trenton T., et al.
Publicado: (2020) -
Acetyl-CoA Carboxylases and Diseases
por: Wang, Yu, et al.
Publicado: (2022) -
WZ66, a novel acetyl-CoA carboxylase inhibitor, alleviates nonalcoholic steatohepatitis (NASH) in mice
por: Gao, Ying-sheng, et al.
Publicado: (2019) -
Chemical Genetics of Acetyl-CoA Carboxylases
por: Zu, Xuyu, et al.
Publicado: (2013) -
Acetyl-CoA carboxylase inhibitor increases LDL-apoB production rate in NASH with cirrhosis: prevention by fenofibrate
por: Dandan, Mohamad, et al.
Publicado: (2023)